These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 15699307

  • 21. Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study.
    Harel Z, Wolter K, Gold MA, Cromer B, Bruner A, Stager M, Bachrach L, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson CC, Burkman R, Bone H.
    J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):209-14. PubMed ID: 20471875
    [Abstract] [Full Text] [Related]

  • 22. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 Aug; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 23. Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.
    Harel Z, Wolter K, Gold MA, Cromer B, Stager M, Johnson CC, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Burkman R, Nelson A, Marshall S, Bachrach LK.
    Contraception; 2010 Dec; 82(6):503-12. PubMed ID: 21074012
    [Abstract] [Full Text] [Related]

  • 24. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [Abstract] [Full Text] [Related]

  • 25. Injectable hormone contraception and bone density: results from a prospective study.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Epidemiology; 2002 Sep; 13(5):581-7. PubMed ID: 12192229
    [Abstract] [Full Text] [Related]

  • 26. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 27. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception.
    Cromer BA, Lazebnik R, Rome E, Stager M, Bonny A, Ziegler J, Debanne SM.
    Am J Obstet Gynecol; 2005 Jan 06; 192(1):42-7. PubMed ID: 15672001
    [Abstract] [Full Text] [Related]

  • 28. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
    Westhoff C.
    J Reprod Med; 1996 May 06; 41(5 Suppl):401-6. PubMed ID: 8725702
    [Abstract] [Full Text] [Related]

  • 29. Bone mineral density and DMPA.
    Westhoff C.
    J Reprod Med; 2002 Sep 06; 47(9 Suppl):795-9. PubMed ID: 12380409
    [Abstract] [Full Text] [Related]

  • 30. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
    Zeman S, Havlík P, Zemanová J, Němec D.
    Ceska Gynekol; 2013 Jan 06; 78(1):116-24. PubMed ID: 23607391
    [Abstract] [Full Text] [Related]

  • 31. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Jul 06; 56(1):1-3. PubMed ID: 9306024
    [Abstract] [Full Text] [Related]

  • 32. Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
    Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE.
    Obstet Gynecol; 1999 Feb 06; 93(2):233-8. PubMed ID: 9932562
    [Abstract] [Full Text] [Related]

  • 33. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec 06; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive.
    Rome E, Ziegler J, Secic M, Bonny A, Stager M, Lazebnik R, Cromer BA.
    J Pediatr Adolesc Gynecol; 2004 Dec 06; 17(6):373-7. PubMed ID: 15603978
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR, Hammond N, Brown HE, Roddy ME.
    J Pediatr Adolesc Gynecol; 2007 Apr 06; 20(2):61-5. PubMed ID: 17418388
    [Abstract] [Full Text] [Related]

  • 39. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z, Gold M, Cromer B, Bruner A, Stager M, Bachrach L, Wolter K, Reid C, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson C, Burkman R, Bone H.
    J Adolesc Health; 2007 Jan 06; 40(1):44-53. PubMed ID: 17185205
    [Abstract] [Full Text] [Related]

  • 40. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P.
    Contraception; 2002 Jun 06; 65(6):407-10. PubMed ID: 12127638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.